Monitoring SARS-CoV-2-specific immunity upon COVID-19 vaccination in nursing home residents and staff Ghent University
Nearly 60% of all COVID-19 deaths in Belgium so far were nursing home (NH) residents. Therefore, in January 2021, Belgium prioritised NH residents and staff for vaccination with the Pfizer-BioNTech (PB) vaccine in the COVID-19 vaccination campaign. The PB vaccine showed 95% efficacy in a phase III trial, but older people were largely underrepresented. This is worrisome, since older adults most often suffer from immunosenescence (decreased ...